Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor- mediated activation of Bruton's tyrosine kinase

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4438-4446

  Buhl, Anne Mette ^a   Cambier, John C ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD19 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PHENYLALANINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; WORTMANNIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CAPPING PHENOMENON; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME REGULATION; GENE MUTATION; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; X LINKED AGAMMAGLOBULINEMIA;

EID: 0033561627     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Cambier, J. C. 1995. Antigen and Fc receptor signaling. J. Immunol. 155:3281.
2. Kurosaki, T. 1997. Molecular mechanisms in B cell antigen receptor signaling. Curr. Opin. Immunol. 9:309.
3. Delfranco, A. L. 1997. The complexity of signaling pathways activated by the BCR. Curr. Opin. Immunol. 9:296.
4. Rawlings, D. J., D. C. Saffran, S. Tsukada, D. A. Largaespada, J. C. Grimaldi, L. Cohen, R. N. Mohr, J. F. Bazan, M. Howard, N. G. Copeland, et al. 1993. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358.
5. Thomas, J. D., P. Sideras, C. I. E. Smith, I. Vorechovsky, V. Chapman, and W. E. Paul. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261:355.
6. Tsukada, S., D. C. Saffran, D. J. Rawlings, O. Parolini, R. C. Allen, I. Klisak, R. S. Sparkes, H. Kubagawa, T. Mohandas, S. Quan, et al. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279.
7. Zhu, Q., M. Zhang, D. J. Rawlings, M. Vihinen, T. Hagemann, D. C. Saffran, S.-P. Kwan, L. Nilsson, C. I. E. Smith, O. N. Witte, et al. 1994. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). J. Exp. Med. 180:461.
8. Conley, M. E. 1992. Molecular approaches to analysis of X-linked immunodeficiencies. Annu. Rev. Immunol. 10:215.
9. Khan, W. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Muller, A. B. Kantor, L. A. Herzenberg, et al. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3:283.
10. Kerner, J. D., M. W. Appleby, R. N. Mohr, S. Chien, D. J. Rawlings, C. R. Maliszewski, O. N. Witte, and R. M. Perlmutter. 1995. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3:301.
11. Kurosaki, T., and M. Kurosaki. 1997. Transphosphorylation of Bruton's tyrosine kinase on tyrosine 551 is critical for B cell antigen receptor function. J. Biol. Chem. 272:15595.
12. Rawlings, D. J., A. M. Scharenberg, H. Park, M. I. Wahl, S. Lin, R. M. Kato, A.-C. Fluckiger, O. N. Witte, and J.-P. Kinet. 1996. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 271:822.
13. Wahl, M. I., A.-C. Fluckiger, R. M. Kato, H. Park, O. N. Witte, and D. J. Rawlings. 1997. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors. Proc. Natl. Acad. Sci. USA 94:11526.
14. Park, H., M. I. Wahl, D. E. H. Afar, C. W. Turck, D. J. Rawlings, C. Tam, A. M. Scharenberg, J.-P. Kinet, and O. N. Witte. 1996. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 4:515.
15. Li, Z., M. I. Wahl, A. Equinoa, L. R. Stephens, P. T. Hawkins, and O. N. Witte. 1997. Phosphatidylinositol 3-kinase-γ activates Bruton's tyrosine kinase in concert with Src family kinases. Proc. Natl. Acad. Sci. USA 94:13820.
16. Fukuda, M., T. Kojima, H. Kabayama, and K. Mikoshiba. 1996. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity. J. Biol. Chem. 271: 30303.
17. Salim, K., M. J. Bottomley, E. Querfurth, M. J. Zvelebil, I. Gout, R. Scaife, R. L. Margolis, R. Gigg, C. I. E. Smith, P. C. Driscoll, et al. 1996. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J. 15:6241.
18. Rameh, L. E., A.-K. Arvidsson, K. L. Carraway III, A. D. Couvillon, G. Rathbun, A. Crompton, B. VanRenterghem, M. P. Czech, K. S. Ravichandran, S. J. Burakoff, et al. 1997. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J. Biol. Chem. 272:22059.
19. Hyvonen, M., and M. Saraste. 1997. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia. EMBO J. 16:3396.
20. Li, T., D. J. Rawlings, H. Park, R. M. Kato, O. N. Witte, and A. B. Satterthwaite. 1997. Constitutive membrane association potentiates activation of Bruton tyrosine kinase. Oncogene 15:1375.
21. Pleiman, C. M., W. M. Hertz, and J. C. Cambier. 1994. Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit. Science 263:1609.
22. Tuveson, D. A., R. H. Carter, S. P. Soltoff, and D. T. Fearon. 1993. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinosilol 3-kinase. Science 260:986.
23. 2+ mobilization. J. Exp. Med. 186:1897.
24. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105.
25. Carter, R. H., G. M. Doody, J. B. Bolen, and D. T. Fearon. 1997 Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex J. Immunol. 158:3062.
26. Tedder, T. F., M. Inaoki, and S. Sato. 1997. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6:107.
27. Justement, L. B., K. S. Campbell, N. C. Chien, and J. C. Cambier. 1991. Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45. Science 252:1839.
28. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376: 352.
29. Saouaf, S. J., S. Mahajan, R. B. Rowley, S. A. Kut, J. Fargnoli, A. L. Burkhardt, S. Tsukada, O. N. Witte, and J. B. Bolen. 1994. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc. Natl. Acad. Sci. USA 91:9524.
30. de Weers, M., G. S. Brouns, S. Hinshelwood, C. Kinnon, R. K. B. Schuurman, R. W. Hendriks, and J. Borst. 1994. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J. Biol. Chem. 269:23857.
31. Sato, S., D. A. Steeber, P. J. Jansen, and T. F. Tedder. 1997. CD19 expression levels regulate B lymphocyte development. J. Immunol. 158:4662.
32. Yamada, H., C. H. June, F. Finkelman, M. Brunswick, M. S. Ring, A. Lees, and J. J. Mond. 1993. Persistent calcium elevation correlates with the induction of surface immunoglobulin-mediated B cell DNA synthesis. J. Exp. Med. 177:1613.
33. Lindsberg, M.-L., M. Brunswick, H. Yamada, A. Lees, J. Inman, C. H. June, and J. J. Mond. 1991. Biochemical analysis of the immune B cell defect in Xid mice. J. Immunol. 147:3774.
34. 2+ following B-cell receptor activation. EMBO J. 17:1973.
35. 2+ mobilization is integrated by CD19 dephosphorylation. Immunity 7:49.
36. Kiener, P. A., M. N. Lioubin, L. R. Rohrschneider, J. A. Ledbetter, S. G. Nadler, and M. L. Diegel. 1997. Co-ligation of the antigen and Fc receptors gives rise to the selective modulation of intracellular signaling in B cells. J. Biol. Chem. 272: 3838.
37. Tsukada, S., M. I. Simon, O. N. Witte, and A. Katz. 1994. Binding of βγ subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase. Proc. Natl. Acad. Sci. USA 91:11256.
38. Bence, K., W. Ma, T. Kozasa, and X.-Y. Huang. 1997. Direct Stimulation of Bruton's tyrosine kinase by Gq-protein α-subunit. Nature 389:296.
39. Yao, L., Y. Kawakami, and T. Kawakami. 1994. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc. Natl. Acad. Sci. USA 91:9175.
40. Yang, W., and S. Desiderio. 1997. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. Proc. Natl. Acad. Sci. USA 94:604.
41. Kikuchi, Y., T. Yasue, K. Miyake, M. Kimito, and K. Takatsu. 1995. CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor α chain: synergistic effects with interleukin 5. Proc. Natl. Acad. Sci. USA 92:11814.
42. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R.F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241.
43. Satterthwaite, A. B., H. Cheroutre, W. N. Khan, P. Sideras, and O. N. Witte. 1997. Btk dosage determines sensitivity to B cell antigen receptor cross-linking. Proc. Natl. Acad. Sci. USA 94:13152.
44. Sato, S., A. S. Miller, M. C. Howard, and T. F. Tedder. 1997. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J. Immunol. 159:3278.
45. Engel, P., L.-J. Zhou, D. C. Ord, S. Sato, B. Koller, and T. F. Tedder. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39.
46. Anderson, J. S., M. Teutsch, Z. Dong, and H. H. Wortis. 1996. An essential role for Bruton's tyrosine kinase in the regulation of B-cell apoptosis. Proc. Natl. Acad. Sci. USA 93:10966.
47. Nemazee, D. A., and K. Burki. 1989 Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562.
48. Venkataraman, C., N. Muthusamy, S. Muthukkumar, and S. Bondada. 1998. Activation of Lyn, Blk, and Btk but not Syk in CD72-stimulated B lymphocytes. J. Immunol. 160:3322.
49. Santos-Argumedo, L., F. E. Lund, A. W. Heath, N. Solvason, W. W. Wu, J. C. Grimaldi, R. M. E. Parkhouse, and M. Howard. 1995. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regulator of CD38 induced signal transduction. Int. Immunol. 7:163.
50. Kitanaka, A., C. Ito, E. Coustan-Smith, and D. Campana. 1997. CD38 Ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with Lyn and phosphatidylinositol 3-kinase. J. Immunol. 159: 184.
51. Venkataraman, C., R. L. Chelvarajan, J. C. Cambier, and S. Bondada. 1998. Interleukin-4 overcomes the negative influence of cyclic AMP accumulation on antigen receptor stimulated B lymphocytes. Mol. Immunol. 35:997.
52. Marengere, L. E. M., K. Okkenhaug, A. Clavreul, D. Couez, S. Gibson, G. B. Mills, T. W. Mak, and R. Rottapel. 1997. The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28. J. Immunol. 159:3220.
53. Bolland, S., R. N. Pearse, T. Kurosaki, and J. V. Ravetch. 1998. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8:509.
54. 3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17:1961.
55. Takata, M., and T. Kurosaki. 1996. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-g2. J. Exp. Med. 184: 31.
56. Huang, C. F., and J. Schmidt. 1994. Calcium influx blocks the skeletal muscle acetylcholine receptor α-subunit gene in vivo. FEBS Lett. 338:277.
57. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440.